Annual EBITDA
$14.52B$5.43B-27.22%
Summary
- Current Value
- As of today, CVS annual EBITDA is $14.52B, down -27.22% on
- Historical Performance
- CVS annual EBITDA is down -25.36% over the past 3 years, and down -14.80% over the past 5 years
- All-Time High Comparison
- CVS annual EBITDA is currently -30.32% below its historical high of $20.83B set on
- 3-Year Low Comparison
- CVS annual EBITDA is at its 3-year low
- Sector Comparison
- CVS annual EBITDA is higher than 99.24% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $14.52B | -27.2% | -25.4% | -14.8% | +85.5% | |
| Quarterly EBITDA | $4.09B | +28.6% | -17.2% | -7.2% | +120.8% | |
| TTM EBITDA | $17.17B | +7.2% | -16.3% | -10.1% | +121.8% | |
| Price | $80.13 | +75.1% | -11.4% | +13.7% | +126.4% | |
| PE Ratio | 209.44 | +1572.8% | +651.5% | +1523.6% | +1373.9% | |
| Annual Revenue | $372.69B | +4.0% | +27.7% | +45.3% | +277.5% | |
| Annual EPS | $3.66 | -43.5% | -38.6% | -28.0% | +43.4% | |
| Annual EBIT | $9.92B | -36.3% | -33.6% | -21.9% | +54.1% | |
| Annual Net Income | $4.59B | -45.2% | -41.9% | -30.8% | +23.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $20.83B | N/A | -30.3% |
| 5Y | $20.83B | -30.3% | |
| All | $20.83B | -30.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $14.52B | at low | |
| 5Y | $14.52B | at low | |
| All | $256.32M | +5563.9% |
EBITDA History
FAQ
What is the current annual EBITDA of CVS?
As of today, CVS annual EBITDA is $14.52B
What is 1-year change in CVS annual EBITDA?
CVS annual EBITDA is down -27.22% year-over-year
What is 3-year change in CVS annual EBITDA?
CVS annual EBITDA is down -25.36% over the past 3 years
How far is CVS annual EBITDA from its all-time high?
CVS annual EBITDA is currently -30.32% below its historical high of $20.83B set on December 31, 2022
How does CVS annual EBITDA rank versus sector peers?
CVS annual EBITDA is higher than 99.24% of companies in Healthcare sector
When is CVS next annual earnings release?
The next annual earnings release for CVS is on
Quarterly EBITDA
$4.09B$392.00M-8.74%
Summary
- Current Value
- As of today, CVS quarterly EBITDA is $4.09B, down -8.74% on
- Historical Performance
- CVS quarterly EBITDA is up +28.55% year-over-year, and down -17.16% over the past 3 years
- All-Time High Comparison
- CVS quarterly EBITDA is currently -30.02% below its historical high of $5.85B set on
- 3-Year Low Comparison
- CVS quarterly EBITDA is +28.55% above its 3-year low of $3.18B reached on
- Sector Comparison
- CVS quarterly EBITDA is higher than 98.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $4.09B | -8.7% | +28.6% | -17.2% | -7.2% | |
| Annual EBITDA | $14.52B | – | -27.2% | -25.4% | -14.8% | |
| TTM EBITDA | $17.17B | +5.6% | +7.2% | -16.3% | -10.1% | |
| Price | $80.13 | +3.4% | +75.1% | -11.4% | +13.7% | |
| PE Ratio | 209.44 | +3.4% | +1572.8% | +651.5% | +1523.6% | |
| Quarterly Revenue | $102.88B | +4.0% | +7.8% | +26.6% | +53.5% | |
| Quarterly EPS | -$3.13 | -489.6% | -4633.1% | -20.9% | -436.5% | |
| Quarterly EBIT | $2.96B | -10.7% | +46.3% | -23.9% | -10.3% | |
| Quarterly Net Income | -$3.99B | -493.9% | -5719.7% | -17.4% | -427.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.23B | -21.7% | |
| 3Y | $5.23B | -21.7% | |
| 5Y | $5.85B | -30.0% | |
| All | $5.85B | -30.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.36B | N/A | +21.9% |
| 3Y | $3.18B | +28.6% | |
| 5Y | $3.18B | +28.6% | |
| All | -$3.90B | +205.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CVS?
As of today, CVS quarterly EBITDA is $4.09B
What is CVS quarterly EBITDA most recent change?
CVS quarterly EBITDA was down -8.74% on September 30, 2025
What is 1-year change in CVS quarterly EBITDA?
CVS quarterly EBITDA is up +28.55% year-over-year
How far is CVS quarterly EBITDA from its all-time high?
CVS quarterly EBITDA is currently -30.02% below its historical high of $5.85B set on June 30, 2022
How does CVS quarterly EBITDA rank versus sector peers?
CVS quarterly EBITDA is higher than 98.83% of companies in Healthcare sector
When is CVS next earnings release?
The next earnings release for CVS is on
TTM EBITDA
$17.17B$909.00M+5.59%
Summary
- Current Value
- As of today, CVS TTM EBITDA is $17.17B, up +5.59% on
- Historical Performance
- CVS TTM EBITDA is up +7.21% year-over-year, and down -16.28% over the past 3 years
- All-Time High Comparison
- CVS TTM EBITDA is currently -17.31% below its historical high of $20.76B set on
- 3-Year Low Comparison
- CVS TTM EBITDA is +18.23% above its 3-year low of $14.52B reached on
- Sector Comparison
- CVS TTM EBITDA is higher than 99.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $17.17B | +5.6% | +7.2% | -16.3% | -10.1% | |
| Annual EBITDA | $14.52B | – | -27.2% | -25.4% | -14.8% | |
| Quarterly EBITDA | $4.09B | -8.7% | +28.6% | -17.2% | -7.2% | |
| Price | $80.13 | +3.4% | +75.1% | -11.4% | +13.7% | |
| PE Ratio | 209.44 | +3.4% | +1572.8% | +651.5% | +1523.6% | |
| TTM Revenue | $393.94B | +1.9% | +6.7% | +24.9% | +48.1% | |
| TTM EPS | $0.38 | -89.3% | -90.3% | -84.4% | -93.7% | |
| TTM EBIT | $12.56B | +8.1% | +9.9% | -22.5% | -14.5% | |
| TTM Net Income | $428.00M | -90.5% | -91.5% | -87.0% | -94.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $17.17B | at high | |
| 3Y | $20.76B | N/A | -17.3% |
| 5Y | $20.76B | -17.3% | |
| All | $20.76B | -17.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.52B | N/A | +18.2% |
| 3Y | $14.52B | +18.2% | |
| 5Y | $14.52B | +18.2% | |
| All | -$3.55B | +583.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CVS?
As of today, CVS TTM EBITDA is $17.17B
What is CVS TTM EBITDA most recent change?
CVS TTM EBITDA was up +5.59% on September 30, 2025
What is 1-year change in CVS TTM EBITDA?
CVS TTM EBITDA is up +7.21% year-over-year
How far is CVS TTM EBITDA from its all-time high?
CVS TTM EBITDA is currently -17.31% below its historical high of $20.76B set on December 31, 2022
How does CVS TTM EBITDA rank versus sector peers?
CVS TTM EBITDA is higher than 99.10% of companies in Healthcare sector
When is CVS next earnings release?
The next earnings release for CVS is on
EBITDA Formula
Data Sources & References
- CVS Official Website www.cvshealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm
- CVS Profile on Yahoo Finance finance.yahoo.com/quote/CVS
- CVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvs